• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NEURONETICS, INC. NEUROSTAR ADVANCED THERAPY; TRANSCRANIAL MAGNETIC STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NEURONETICS, INC. NEUROSTAR ADVANCED THERAPY; TRANSCRANIAL MAGNETIC STIMULATOR Back to Search Results
Model Number NEUROSTAR ADVANCED THERAPY V3.0
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Convulsion/Seizure (4406)
Event Date 12/19/2023
Event Type  Injury  
Manufacturer Narrative
Neuronetics was contacted by a provider who reported that one of their patients had experienced a seizure about 8 minutes into their 2nd treatment session.Patient was monitored at the office after the seizure occurred and left the office with his mother.Per the provider, patient had recently started buproprion prior to beginning tms.Buproprion is known to potentially lower the seizure threshold in patients.Following the event, the provider decided to discontinue the patient's buproprion.The patient did not continue tms treatment.
 
Event Description
Neuronetics was contacted by a provider reporting that one of their patients had experienced a seizure during their 2nd treatment session.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEUROSTAR ADVANCED THERAPY
Type of Device
TRANSCRANIAL MAGNETIC STIMULATOR
Manufacturer (Section D)
NEURONETICS, INC.
3222 phoenixville pike
malvern PA 19355
Manufacturer (Section G)
NEURONETICS, INC.
3222 phoenixville pike
malvern PA 19355
Manufacturer Contact
anna gorbunov
3222 phoenixville pike
malvern, PA 19355
6106404202
MDR Report Key18525091
MDR Text Key333024812
Report Number3004824012-2024-00003
Device Sequence Number1
Product Code OBP
UDI-Device Identifier00869378000117
UDI-Public00869378000117
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K220127
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 01/17/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberNEUROSTAR ADVANCED THERAPY V3.0
Device Catalogue Number81-02315-000
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/19/2023
Initial Date FDA Received01/17/2024
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
BUPROPRION 150 MG DAILY.; BUSPIRONE 15 MG DAILY.; L-GLUTAMINE 500 MG TWICE A DAY.; L-METHYLFOLATE 15 MG DAILY.; LAMOTRIGINE 150 MG DAILY.; VITAMIN D3.; VRAYLAR 1.5 MG DAILY.
Patient Outcome(s) Other;
Patient Age19 YR
Patient SexMale
Patient Weight86 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-